DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr | ₹7.06 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹8.00 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹89 Cr |
| Mar2021 | ₹7.06 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.00 Cr | -96.89 | |
| Mar2024 | ₹257 Cr | 188.76 | |
| Mar2023 | ₹89 Cr | -0.03 | |
| Mar2022 | ₹89 Cr | 1,161.05 | |
| Mar2021 | ₹7.06 Cr | - | |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,030.6 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
| MANKIND PHARMA | ₹104,478.0 Cr | 7% | 2% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.3% |
-2.1% |
3.8% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses